These results support developing combination therapy using targeting agents against each GSC state, such as Notch inhibitors (Park et al., 2017) and small molecule inhibitors of ALDH (Cheng et al., 2016), to eradicate self-renewing tumor-initiating cells with the hope to cure GBM patients. The gene discussed is LDHA; the disease is neoplasm.